Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study

by Wouter A. M. Broos, Maurits Wondergem, Remco J. J. Knol, Friso M. van der Zant
Published 2019-07-01

18F-DCFPyL PET/CT in primary staging of prostate cancer

by Maurits Wondergem, Friso M van der Zant, Ton A Roeleveld, Sandra Srbljin, Marina S Kartachova, Annemarie van Dongen, Vera Franken, Remco J J Knol
Published 2018-10-01

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy

by Frank J. Borm, Jasper Smit, Daniela E. Oprea-Lager, Maurits Wondergem, John B. A. G. Haanen, Egbert F. Smit, Adrianus J. de Langen
Published 2021-06-01

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.

by Dennie Meijer, Bernard H E Jansen, Maurits Wondergem, Yves J L Bodar, Sandra Srbljin, Annelies E Vellekoop, Bram Keizer, Friso M van der Zant, Otto S Hoekstra, Jakko A Nieuwenhuijzen, Max Dahele, André N Vis, Daniela E Oprea-Lager
Published 2020-01-01